MAPK7 and colorectal carcinoma: Recently, CDK5 has been shown to activate the ERK5–AP-1 (activator protein-1) signaling axis through phosphorylation of ERK5 at Thr732, providing evidence that the CDK5–ERK5–AP-1 axis can promote CRC carcinogenesis [50].